Popular Articles

Initial Therapy With Janumet™ Provided Significantly Greater Blood Sugar Lowering Compared To Metformin Alone In Type 2 Diabetes
New data presented at the American Diabetes Association (ADA) 69th Annual Scientific Sessions showed that initial treatment with "Janumet"* (sitagliptin/metformin) provided significantly greater blood sugar improvements in drug-naç¯ve** patients with type 2 diabetes, compared with metformin alone.[i]
generic viagra online
Unlocking The Mysteries Of The Brain: Investigators Search For Answers About Injuries, PTSD
In the first study of its kind, researchers at Saint Louis University are recruiting patients for a clinical trial that will use cutting-edge imaging equipment to map the brain injuries of combat veterans and civilians, aiming to better understand the nature of their injuries. Funded by a $5.3 million grant from the U.S. Department of Defense, researchers will use three types of imaging equipment together, producing better data and a more complete taxonomy of brain injuries, information that investigators hope may lead to better treatment for blast injuries and car accidents.
News of the day
UK Travellers Could Pay The Price For Paradise - More Brits Considering Long Haul Trips But Ignoring The Threat Of Malaria
Brits taking advantage of last-minute credit crunch deals to tropical destinations could be seriously risking their health, according to a survey of over 1,000 UK travellers.1
Mental Health

CPhA Applauds Efforts To Help Seniors Afford Prescription Medications

Congressional leaders and leading pharmaceutical companies have come up with a plan to reduce medication costs for millions of senior citizens enrolled in the Medicare Part D Prescription Drug program. In combination with other discount programs and rebates, the savings to the U.S. government could represent $80 billion. The Pharmaceutical Research and Manufacturers of America (PhRMA) is leading the charge to specifically close the coverage gap for patients whose medications costs fall into the "doughnut hole." Seniors prescription medication costs fall into the "doughnut hole" (above $2,700 but lower than $6,153.75 per year) and then they must pay out of pocket for their prescriptions. Affordability and adherence to medication become serious issues that can compromise their care when this occurs. "This announcement could not have come at a better time," states Lynn Rolston, Chief Executive Officer of the California Pharmacists Association. "In order to maintain patients" health and keep health care costs down, it is critical for patients to adhere to their medication therapies." "Under the proposed plan, pharmaceutical companies will provide a 50 percent discount to most beneficiaries on brand-name medicines covered by a patient"s Part D plan when purchased in the coverage gap," states PhRMA President and CEO Billy Tauzin. "In addition, the entire negotiated price of the Part D covered medicine purchased in the coverage gap would count toward the beneficiary"s out-of-pocket costs, thus lowering their total out-of-pocket spending. Importantly, the proposal would not require any additional paperwork on the part of the beneficiary nor would an asset test be used for eligibility." As this program rolls out, CPhA will be monitoring the implementation plans and providing assistance where appropriate to ensure that patients get the full intended value. It will be critical that pharmacists are treated fairly and given enough information to administer this program smoothly. For now, the news seems very positive and pharmacists stand ready to support this effort. California Pharmacists Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):